A novel homozygous MPV17 mutation in two families with axonal sensorimotor polyneuropathy

Yu-Ri Choi1, Young Bin Hong2, Sung-Chul Jung3

  • 1Department of Biochemistry, Ewha Womans University School of Medicine, Seoul, Korea. power_upup@naver.com.

BMC Neurology
|October 7, 2015
PubMed
Abstract

Insights

Mutations in the MPV17 gene cause a rare neuropathy. This study identifies a new MPV17 mutation in patients with axonal sensorimotor polyneuropathy, expanding the known disease spectrum.

Area of Science:

  • Genetics
  • Neurology
  • Mitochondrial Biology

Background:

  • Mutations in MPV17 cause mitochondrial DNA depletion syndrome 6 (MTDPS6), also known as Navajo neurohepatopathy (NNH).
  • MTDPS6 typically presents with infantile liver failure and sometimes neurological issues.

Purpose of the Study:

  • To identify the genetic cause of neuropathy in two unrelated patients.
  • To expand the understanding of MPV17-related disorders.

Main Methods:

  • Whole exome sequencing (WES) was used to identify the causative gene.
  • Clinical assessments, biochemical analysis, and in vitro assays with mouse motor neuronal cells were performed.

Main Results:

  • A novel homozygous MPV17 mutation (p.R41Q) was identified in both patients.
  • Patients presented with axonal sensorimotor polyneuropathy, distinct from typical MTDPS6 liver/brain involvement.
  • MPV17 abrogation and mutant protein expression impaired neuronal cell integrity and proliferation.

Conclusions:

  • A novel MPV17 mutation causes axonal sensorimotor polyneuropathy without hepatoencephalopathy.
  • This expands the clinical spectrum of MPV17-related disorders.
  • MPV17 gene screening is recommended for axonal peripheral neuropathies.